Europe — EMA

Ondansetron Kalceks

Ondansetron, the active ingredient in Ondansetron Kalceks, is a 5-HT3 receptor antagonist presented as a unknown/unknown for Intravenous use.

Ondansetron

Request sourcing

Pack/s

What is Ondansetron?

Ondansetron, the active ingredient in Ondansetron Kalceks, is a 5-HT3 receptor antagonist presented as a unknown/unknown for Intravenous use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery in adults and children. GNH USA supplies Ondansetron Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Ondansetron Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Ondansetron used for?

Ondansetron Kalceks is a selective 5‑HT3 receptor antagonist that acts on the central and peripheral pathways of nausea and vomiting. - Chemotherapy‑induced nausea and vomiting (CINV): prevents the ab ... … … … … … - ... … ... ...

What are the side effects of Ondansetron?

Common ... … ...

What precautions apply to Ondansetron?

… place …

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →